Seer

The trait that decides it is where the work starts. Most agents begin with a diff and ask what might break; this one begins with something that already broke and works backwards, which means the fix arrives attached to the triage ticket you were going to open anyway. That ordering saves the step everyone actually hates.

It is narrow by the same logic: no error, no value. Pick it when production noise is what your week looks like. Pick Baz when the review queue is the thing that hurts instead.

The limitation is stated plainly and it is severe for the buyers most likely to want this. Organisations running their own code host, which tend to be the regulated ones with the largest error volumes, get the analysis and not the automated change, because the integration reaches only the hosted editions. That turns the headline capability into a feature half the market cannot buy.

What it does right is delegation. It can hand implementation to an external coding agent instead of insisting on being the one that writes the patch.

1. Root-cause analysis here starts from runtime evidence: a stack, a trace across services, and a profile showing what actually executed. That is a different and stronger input than static inspection, because it records what happened rather than what could. 2. It also bounds the problem, since the failure is already localised before reasoning begins.

2. No accuracy figure is published. For a product whose claim is causal identification, the absence of a measured hit rate against known root causes is the one number a reader wants.

The strategic logic is close to airtight. The hard input, years of structured production telemetry per customer, was accumulated by a business that already charges for it, so the agent is incremental margin on an asset with a switching cost measured in instrumentation work. Nobody wrapping a frontier model can replicate that from outside.

Pricing power is therefore real, because the alternative to renewing is re-instrumenting. Likely path: this becomes a default tier rather than an add-on. Position: buy it if you are already a customer, and treat the monitoring lock-in as the thing you are actually renewing.

The unit is unusual and I have mixed feelings about it. Only developers who open at least two pull requests a month against an enabled repository count, so of sixty engineers perhaps forty bill in a busy month and thirty in a quiet one, which is fairer than seats and impossible to forecast to the finance team.

Enabling it per project and per repository is the control I need, so exposure can be grown deliberately. It is an add-on to a subscription we already hold. Approved with conditions: two repositories first, and a three-month billing history before we widen it.

There is one door and it faces outward. The platform ships a server for the protocol, so an agent I wrote can query the same issue data without adopting this product at all, and that is a genuinely useful escape hatch for someone who wants the telemetry and not the opinion.

The product itself is sealed: proprietary licence, undisclosed model, and nothing runs on hardware I own. Nothing survives the vendor because nothing is distributable. I would use the server and write my own analysis, which is the honest version of my position here.